HomeInsightsStock Comparison

Alivus Life Sciences Ltd vs Supriya Lifescience Ltd Stock Comparison

Alivus Life Sciences Ltd vs Supriya Lifescience Ltd Stock Comparison

Last Updated on: Jun 23, 2025

Key Highlights

  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 991.6 as of 23 Jun 10:25.
  • The P/E Ratio of Alivus Life Sciences Ltd changed from 13.4 on March 2022 to 20.2 on March 2024 . This represents a CAGR of 14.66% over 3 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 22.4 on March 2024 . This represents a CAGR of -4.97% over 3 years.
  • The Market Cap of Alivus Life Sciences Ltd changed from ₹ 5624 crore on March 2022 to ₹ 9499 crore on March 2024 . This represents a CAGR of 19.09% over 3 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 2670 crore on March 2024 . This represents a CAGR of -12.36% over 3 years.
  • The revenue of Alivus Life Sciences Ltd for the Mar '25 is ₹ 659.63 crore as compare to the Dec '24 revenue of ₹ 652.3 crore. This represent the growth of 1.12% The revenue of Supriya Lifescience Ltd for the Mar '25 is ₹ 187.08 crore as compare to the Dec '24 revenue of ₹ 187.75 crore. This represent the decline of -0.36%.
  • The ebitda of Alivus Life Sciences Ltd for the Mar '25 is ₹ 208.52 crore as compare to the Dec '24 ebitda of ₹ 200.76 crore. This represent the growth of 3.87% The ebitda of Supriya Lifescience Ltd for the Mar '25 is ₹ 70.56 crore as compare to the Dec '24 ebitda of ₹ 68.05 crore. This represent the growth of 3.69%.
  • The net profit of Alivus Life Sciences Ltd changed from ₹ 135.45 crore to ₹ 141.87 crore over 8 quarters. This represents a CAGR of 2.34% The net profit of Supriya Lifescience Ltd changed from ₹ 28.51 crore to ₹ 50.38 crore over 8 quarters. This represents a CAGR of 32.93% .
  • The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 19.96 % on March 2020 to 5.41 % on March 2024 . This represents a CAGR of -22.98% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alivus Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

About Supriya Lifescience Ltd

  • Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
  • The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
  • Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
  • It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
  • The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

Alivus Life Sciences Ltd News Hub

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

News

Glenmark Life Sciences renamed as Alivus Life Sciences

Glenmark Life Sciences announced its change of identity to Alivus Life Sciences, marking a...

Read more

20 Jan 2025 10:18

Supriya Lifescience Ltd News Hub

News

Board of Supriya Lifesciences recommends final dividend

Supriya Lifesciences announced that the Board of Directors of the Company at its meeting h...

Read more

27 May 2025 19:48

News

Supriya Lifesciences to announce Quarterly Result

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 27 Ma...

Read more

21 May 2025 19:30

News

Board of Supriya Lifescience appoints company secretary and compliance officer

The Board of Supriya Lifescience at its meeting held on 10 March 2025 has approved the app...

Read more

10 Mar 2025 15:37

News

Supriya Lifesciences to hold board meeting

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 10 Ma...

Read more

06 Mar 2025 09:34

News

Supriya Lifesciences declare Quarterly Result

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 24 Ja...

Read more

17 Jan 2025 11:05

News

Supriya Lifescience inaugurates new API production block at Lote Parshuram site

Supriya Lifescience  inaugurated its new multipurpose Active Pharmaceutical Ingredients (A...

Read more

17 Dec 2024 16:57

SWOT Analysis Of Supriya Lifescience Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Supriya Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alivus Life Sciences Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Supriya Lifescience Ltd?

Market cap of Alivus Life Sciences Ltd is 12,264 Cr while Market cap of Supriya Lifescience Ltd is 5,484 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Supriya Lifescience Ltd?

The stock performance of Alivus Life Sciences Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Supriya Lifescience Ltd?

As of June 23, 2025, the Alivus Life Sciences Ltd stock price is INR ₹1000.1. On the other hand, Supriya Lifescience Ltd stock price is INR ₹681.5.

How do dividend payouts of Alivus Life Sciences Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions